- Quince Therapeutics Inc Annual Shareholders Meeting TranscriptMay 24, 2023
- Cortexyme Inc To Discuss The GAIN Trial Top-Line Results Call TranscriptOct 26, 2021
- Cortexyme Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2021
- Cortexyme Inc at Canaccord Genuity Growth Conference (Virtual) TranscriptAug 11, 2021
- Cortexyme Inc Corporate To Discuss Innovation in Alzheimers Disease -- Getting to the Root Cause of Neurodegeneration Webinar TranscriptJul 30, 2021
- Cortexyme Inc Corporate To Discuss Innovation in Periodontal Disease -- A Major Unmet Medical Need Webinar TranscriptJul 23, 2021
- Cortexyme Inc at JMP Securities Life Sciences Virtual Conference TranscriptJun 16, 2021
- Cortexyme Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2021
- Cortexyme Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Cortexyme Inc at Stifel CNS Day - Fireside Chat TranscriptApr 01, 2021
- Cortexyme Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 16, 2021
- Cortexyme Inc GAIN Trial Interim Analysis Update Call TranscriptDec 04, 2020
Cortexyme Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Okay. Good afternoon, everyone.
Good afternoon.
Sorry about the delay. We have the management team of Cortexyme with us this afternoon. We're very pleased to have them with us. We have Casey Lynch, CEO; we have Chris Lowe, the CFO; and we have Mike Detke, the CMO, with us this afternoon. So thank you very much for joining us. Let's turn the call over to Chris Lowe.
Great. Good afternoon, everybody. I am Chris Lowe, Chief Operating Officer and Chief Financial Officer at Cortexyme. If you're new to Cortexyme, I think you will appreciate the elegance of our evidence to date.
Our proprietary library of small molecules target a pathogen, which we believe is upstream of other targets within many areas of CNS. We absolutely believe this is the game changer patients have been waiting for. I'm very excited to share our progress
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)